OCUGEN, INC. (OCGN) Pre-Tax Margin
- 2022-12-31: Pre-Tax Margin -3116.27%.
Complete source-backed pre-tax margin history.
- Available history
- 2020-12-31 to 2025-12-31
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2022-12-31 | -3116.27% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2025-12-31 | -1537.41% |
| 2024-12-31 | -1333.02% |
| 2023-12-31 | -1045.03% |
| 2022-12-31 | -3488.91% |
| 2020-12-31 | -50748.84% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |